NOVOLIN 70/30

LOE Approaching

human insulin

BLAINJECTIONINJECTABLE
Approved
Jun 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

insulin, including NOVOLIN 70/30, is the regulation of glucose metabolism. Insulins lower blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production. Insulin inhibits lipolysis and proteolysis, and enhances protein…

Pharmacologic Class:

Insulin

Clinical Trials (5)

NCT07255807N/ANot Yet Recruiting

Defining the Human Insulin Resistance Molecular Network; SIGNATURE

Started Dec 2025
80 enrolled
Metabolic HealthInsulin Sensitivity/Resistance
NCT02109029Phase 1Completed

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

Started Apr 2014
24 enrolled
Diabetes Mellitus, Type 1
NCT01892020Phase 4Completed

Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus

Started Jun 2013
161 enrolled
DiabetesDiabetes Mellitus, Type 2
NCT01790438Phase 3Completed

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes

Started Mar 2013
641 enrolled
Diabetes Mellitus, Type 2
NCT00888732Phase 3Completed

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin

Started Jun 2009
24 enrolled
Diabetes Mellitus, Type 1